Anagrelide is an effective platelet-lowering agent, but its role in the treatment of essential thrombocythaemia has yet to be fully determined Drug and Profile Reports 31 August 2012 Pages: 1 - 5
Decitabine in myelodysplastic syndromes: profile report Drug and Profile Reports 31 August 2012 Pages: 6 - 7
Effective identification, treatment and prevention is key in the war on tuberculosis Disease Management 31 August 2012 Pages: 8 - 12
Although far from ideal, long-term systemic corticosteroids may be necessary in treating severe refractory asthma Disease Management 31 August 2012 Pages: 13 - 16
Aggressive risk factor modification and pharmacological therapy are the basic steps in managing peripheral arterial disease Disease Management 31 August 2012 Pages: 17 - 20
First reports of serious adverse drug reactions in recent weeks Drug Reactions and Interaction 31 August 2012 Pages: 21 - 21
Potential for modest differences between sexes in antiretroviral therapy pharmacokinetics and adverse events Drug Reactions and Interactions 31 August 2012 Pages: 22 - 24
Assessment of direct-to-consumer advertising of prescription drugs must consider the implications on appropriate drug use Practical Issues and Updates 31 August 2012 Pages: 24 - 26
